'Lymphoid' blast crisis of chronic myeloid leukaemia is associated with distinct clinicohaematological features

British Journal of Haematology

Volumn 100, Issue 1, 1998, Pages 129-134

  Cervantes, Francisco ^a,b   Villamor, Neus ^a   Esteve, Jordi ^a   Montoto, Silvia ^a   Rives, Susana ^a   Rozman, Ciril ^a   Montserrat, Emilio ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Chronic myeloid leukaemia; Lymphoid blast crisis

Indexed keywords

ANTINEOPLASTIC AGENT; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BLAST CELL CRISIS; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; FEMALE; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; LYMPHOBLAST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL TIME;

EID: 0031961758     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00542.x     Document Type: Article

References (33)

1. Alimena, G., Dallapiccola, B., Gastaldi, R., Mandelli, F., Brandt, L., Mitelman, F. & Nilsson, P.G. (1982) Chromosomal, morphological and clinical correlations in blastic crisis of chronic myeloid leukaemia: a study of 69 cases. Scandinavian Journal of Haematology, 28, 103-117.
2. Bakhshi, A., Minowada, J., Arnold, A., Cossman, J., Jensen, J.P., Whang-Peng, J., Waldmann, T.A. & Korsmeyer, S.J. (1983) Lymphoid blast crises of chronic myelogenous leukaemia represent stages in the development of B-cell precursors. New England Journal of Medicine, 309, 826-831.
3. Becher, R., Carbonell, F. & Bartram, C.R. (1990) Isochromosome 17q in Ph-negative leukemia: a clinical, cytogenetic, and molecular study. Blood, 75, 1679-1683.
4. Bene, M.C., Castoldi, G., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A. & van't Veer, M.B. (1995) Proposals for the immunological classification of acute leukemias: European Group for the Immunological Characterisation of Leukemias (EGIL). Leukemia, 9, 1783-1786.
5. Bettelheim, P., Lutz, D., Majdic, O., Paietta, E., Haas, O., Linkesh, W., Neumann, E., Lechner, K. & Knapp, W. (1985) Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia. British Journal of Haematology, 59, 395-409.
6. Canellos, G.P., De Vita, V.T., Jr. Whang-Peng, J., Chabner, B.A., Schein, P.S. & Young, R.C. (1976) Chemotherapy of the blast phase of chronic granulocytic leukemia: hypodiploidy and response to therapy. Blood, 47, 1003-1009.
7. Cervantes, F., López-Guillermo, A., Bosch, F., Terol, M.J., Rozman, C. & Montserrat, E. (1996) An assessment of the clinicohaematological criteria for the accelerated phase of chronic myeloid leukaemia. European Journal of Haematology, 57, 286-291.
8. Cervantes, F. & Rozman, C. (1982) A multivariate analysis of prognostic factors in chronic myeloid leukemia. Blood, 60, 1298-1304.
9. Cervantes, F., Rozman, M., Rosell, J., Urbano-Ispizua, A., Montserrat, E. & Rozman, C. (1990) A study of prognostic factors in blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia. British Journal of Haematology, 76, 27-32.
10. Coleman, M., Silver, R.T., Pajak, T.F., Cavalli, F., Rai, K.R., Kostinas, J.E., Glidewell, O. & Holland, J. (1980) Combination chemotherapy for terminal phase chronic granulocytic leukemia: Cancer and Leukemia Group B studies. Blood, 55, 29-36.
11. Derderian, P.M., Kantarjian, H.M., Talpaz, M., O'Brien, S., Cork, A., Estey, E., Pierce, S. & Keating, M. (1995) Chronic myelogenous leukemia in the lymphoid blastic phase: characteristics, treatment response, and prognosis. American Journal of Medicine, 94, 69-74.
12. Drexler, H.G., Thiel, E. & Ludwig, W.D. (1991) Review of incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia, 5, 637-645.
13. García-Isidoro, M., Tabernero, M.D., Nájera, M.L., López-Bergés. M.C., Martínez, A., Durán, A., García, J.L., Hernández, J.M., García Marcos, M.A., San Miguel, J.F. & Orfao, A. (1997) Association between trisomy 8 and the immunophenotype of blast cells from acute leukaemia secondary to a myelodysplastic syndrome or chronic myeloproliferative disorders. Annals of Hematology. 74, 209-214.
14. Greaves, M.F., Chan, L.C., Furley, A.J.W., Watt, S.M. & Molgaard, H.V. (1986) Lineage promiscuity in hemopoietic differentiation and leukemia. Blood, 67, 1-11.
15. Griffin, J.D., Todd, R.F., Ritz, J., Nadler, L.M., Canellos, G.P., Rosenthal, D., Beveridge, R.P. Weinstein, H., Karp, D. & Schlossman, S.F. (1983) Differentiation patterns in the blastic phase of chronic myeloid leukemia. Blood. 6, 85-91.
16. Hernández, J.M., González-Sarmiento, R., Martín, C., González, M., Sånchez, I., Corral, J., Orfao, A., Cañizo, C., San Miguel, J.F. & López-Borrasca, A. (1991) Immunophenotypic, genomic and clinical characteristics of blast crisis of chronic myelogenous leukaemia. British Journal of Haematology, 79, 408-414.
17. Janossy, G., Woodruff, R.K., Peppard, M.J., Prentice, G., Hoffbrand, A.V., Paxton, A., Lister, A., Bunch, C. & Greaves, M.F. (1979) Relation to 'lymphoid' phenotype and response to chemotherapy incorporating vincristine-prednisone in the acute phase of Ph positive leukemia. Cancer, 43, 426-434.
18. Kantarjian, H.M., Dixon, D., Keating, M.J., Talpaz, M., Walters, R.S., McCredie, K.B. & Freireich, E.J. (1988) Characteristics of accelerated disease in chronic myelogenous leukemia. Cancer, 61, 1441-1446.
19. Kantarjian, H.M., Keating, M.J., Talpaz, M., Walters, S.R., Smith, T.L., Cork, A., McCreedìe, K.B. & Freireich, E.J. (1987) Chronic myelogenous leukemia in blast crisis: analysis of 242 patients. American Journal of Medicine, 83, 445-454.
20. Kaplan, G. & Meier, P. (1985) Nonparametric estimation for incomplete observations. Journal of the American Statistical Association, 53, 457-463.
21. Keating, M.J., Smith, T.L., Kantarjian, H. & Cork, A. (1988) Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant to outcome. Leukemia 2, 403-412.
22. Laporte, J.P., Gorin, N.C., Rubinstein, P., Lesage, S., Portnoi, M.F., Barbu, V., López, M., Douay, L. & Najman, A. (1996) Cord-blood transplantation from an unrelated donor in an adult with chronic myelogenous leukemia. New England Journal of Medicine, 335. 167-174.
23. Marks, S.M., Baltimore, D. & McCaffrey, R. (1978) Terminal transferase as a predictor of initial responsiveness to vincristine and prednisone in blastic chronic myelogenous leukemia. New England Journal of Medicine, 298, 812-814.
24. Mitelman, F. (ed.) (1995) An International System for Human Cytogenetic Nomenclature. Karger, Basel.
25. Parreira, L., Kearney, L., Rassool, F., Babapulle, V.B., Matutes, E., Parreira, A., Taveres de Castro. J., Goldman, J.M. & Catovsky, D. (1986) Correlation between chromosomal abnormalities and blast phenotype in the blast crisis of Ph-positive CGL. Cancer Genetics and Cytogenetics, 22, 29-54.
26. 2/E in the logrank test for survival data on tumor incidence data. Biometrics, 29, 579-584.
27. Saikia, T., Advani, S., Dasgupta, A., Ramakrishnan, G., Nair, C., Gladstone, B., Kumar, M.S.A., Badrinath, Y. & Dhond, S. (1988) Characterization of blast cells during blastic phase of chronic myeloid leukemia by immunophenotyping: experience in 60 patients. Leukemia Research, 12, 499-506.
28. Schmetzer, H.M. & Gerhartz, H.H. (1997) Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation, and acute lymphoblastic leukemia. Experimental Hematology, 25, 502-508.
29. Spencer, A., Vulliamy, T., Kaeda, J., Goldman, J.M. & Melo, J.V. (1997) Clonal instability preceding lymphoid blastic transformation of chronic myeloid leukemia. Leukemia, 11, 195-201.
30. Urbano-Ispizua, A., Cervantes, E., Matutes, E., Villamor, N., Pujades, A., Sierra, J., Feliu, E., Vives-Corrons, J.L., Montserrat, E. & Rozman, C. (1993) Immunophenotypic characteristics of blast crisis of chronic myeloid leukemia: correlations with clinico-biological features and survival, Leukemia, 7, 1349-1354.
31. Urbano-Ispizua, A., Matutes, E., Villamor, N., Ribera, J.M., Feliu, E., Montserrat, E., Grañena, A., Vives-Corrons, J.L. & Rozman, C. (1990) Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukaemia. British Journal of Haematology. 75, 202-207.
32. Walters, R.S., Kantarjian, H.M., Keating, M.J., Talpaz, M., Childs, C.C., MeCredie, K.N., Freireich, E.J. (1987) Therapy of lymphoid and undifferentiated chronic myelogenous leukemia in blast crisis with continuous vincristine and adriamycin infusions plus high-dose decadron. Cancer, 60, 1708-1712.
33. Yunis, J.J., Lobell, M., Arnesen, M.A., Oken, M.M., Mayer, M.G., Rydell, R.E. & Brunning. R.D. (1988) Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogenous leukaemia. British Journal of Haematology, 68, 189-194.